Position in DNA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$23,701,241
+$9,040,433 QoQ
Shares Held
2,391,649
0.0% QoQ
Ownership
3.55%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $3,256,235,173 across 13 Biotechnology names. DNA ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
18,206,778 | $1,275,020,662 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,439,889 | $734,479,783 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,015,578 | $561,573,456 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
11,960,230 | $307,617,113 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,561 | $135,389,224 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,487,907 | $86,200,617 | |
| 7 | BNTX |
BioNTech SE
|
592,380 | $55,120,957 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
263,466 | $49,341,910 |
All Filings in DNA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,701,241 | 2,391,649 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $14,660,808 | 2,391,649 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $19,874,603 | 2,391,649 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $47,170,001 | 3,235,254 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $36,855,573 | 3,276,051 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $19,100,077 | 3,350,891 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $32,969,528 | 3,357,386 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $27,372,433 | 3,358,581 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $44,898,238 | 134,425,866 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $270,279,618 | 232,999,673 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $399,333,787 | 236,292,183 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $432,243,968 | 238,808,823 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $448,411,411 | 241,081,405 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $323,014,784 | 242,868,260 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $412,658,525 | 244,176,643 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $636,719,748 | 204,076,843 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $488,680,129 | 205,327,786 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $676,043,298 | 167,752,680 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $909,530,920 | 109,450,171 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $1,054,722,566 | 91,002,810 | Shares | Defined | 2021-10-19 | |
| No filing history on record for this holder in this stock. | ||||||